The "Los Angeles Times" quoted Professor Hank Greely in a story about the California Supreme Court's decision to approve California's $3 billion stem cell program:

"Although some might think the U.S. Supreme Court could have a majority of justices unsympathetic to embryonic stem cell research, there is no plausible federal law claim in their case for the Supreme Court to hear," said Hank Greely, a Stanford University law professor who specializes in health law and bioscience.

"We're ahead of everybody else, and we'll stay ahead of everybody else," Greely said.